Margaret E. Hoadley

The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial

Navneet Singh, Stephen J. Hopkins, Sharon Hulme et al. · Journal of Neuroinflammation · 2014 · 288 citations · Full text

Medicine, Neurology, Neurosurgery +17

SCIL-STROKE (Subcutaneous Interleukin-1 Receptor Antagonist in Ischemic Stroke)

Craig J. Smith, Sharon Hulme, Andy Vail et al. · Stroke · 2018 · 195 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Long-Term Intracerebroventricular Infusion of Corticotropin-Releasing Hormone Alters Neuroendocrine, Neurochemical, Autonomic, Behavioral, and Cytokine Responses to a Systemic Inflammatory Challenge

Astrid C. E. Linthorst, Cornelia Flachskamm, Stephen J. Hopkins et al. · Journal of Neuroscience · 1997 · 166 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) study

James Galea, Kayode Ogungbenro, Sharon Hulme et al. · Journal of neurosurgery · 2017 · 128 citations · Full text

Medicine, Neurosurgery, Pharmacology +16

CLINICAL EVALUATION OF A TWO‐SITE IMMUNORADIOMETRIC ASSAY FOR ADRENOCORTICOTROPIC IN UNEXTRACTED HUMAN PLASMA USING MONOCLONAL ANTIBODIES

Anne White, Haley Hunter Smith, Margaret E. Hoadley et al. · Clinical Endocrinology · 1987 · 109 citations

Life Sciences, Endocrinology, Clinical Biochemistry +16